SrasV1, Ncbi, Merge, bibRecord, 001914

Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus.

Identifieur interne : 001914 ( Ncbi/Merge ); précédent : 001913; suivant : 001915

Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus.

Auteurs : Jincun Zhao [République populaire de Chine] ; Qianrong Huang ; Wei Wang ; Yan Zhang ; Ping Lv ; Xiao-Ming Gao

Source :

Journal of virology [ 0022-538X ] ; 2007.

RBID : pubmed:17392374

Descripteurs français

English descriptors

KwdEn :
- Amino Acid Sequence, Animals, Cell Line, Chlorocebus aethiops, Epitopes, T-Lymphocyte (administration & dosage), Epitopes, T-Lymphocyte (chemistry), Epitopes, T-Lymphocyte (isolation & purification), Female, Humans, Immunodominant Epitopes (administration & dosage), Immunodominant Epitopes (chemistry), Immunodominant Epitopes (isolation & purification), Male, Mice, Mice, Inbred BALB C, Mice, Inbred C3H, Mice, Inbred C57BL, Molecular Sequence Data, Nucleocapsid Proteins (administration & dosage), Nucleocapsid Proteins (chemistry), Nucleocapsid Proteins (isolation & purification), SARS Virus (chemistry), SARS Virus (immunology), T-Lymphocytes, Helper-Inducer (immunology), T-Lymphocytes, Helper-Inducer (virology), Vero Cells.
MESH :
- chemical , administration & dosage : Epitopes, T-Lymphocyte, Immunodominant Epitopes, Nucleocapsid Proteins.
- chemical , chemistry : Epitopes, T-Lymphocyte, Immunodominant Epitopes, Nucleocapsid Proteins.
- chemical , isolation & purification : Epitopes, T-Lymphocyte, Immunodominant Epitopes, Nucleocapsid Proteins.
- chemistry : SARS Virus.
- immunology : SARS Virus, T-Lymphocytes, Helper-Inducer.
- virology : T-Lymphocytes, Helper-Inducer.
- Amino Acid Sequence, Animals, Cell Line, Chlorocebus aethiops, Female, Humans, Male, Mice, Mice, Inbred BALB C, Mice, Inbred C3H, Mice, Inbred C57BL, Molecular Sequence Data, Vero Cells.

Abstract

By using a series of overlapping synthetic peptides covering 98% of the amino acid sequence of the nucleocapsid protein (NP) of severe acute respiratory syndrome coronavirus (SARS-CoV), four helper T-cell (Th) epitopes (NP11, residues 11 to 25; NP51, residues 51 to 65; NP61, residues 61 to 75; and NP111, residues 111 to 125) in C57BL mice (H-2(b)), four (NP21, residues 21 to 35; NP91, residues 91 to 105; NP331, residues 331 to 345; and NP351, residues 351 to 365) in C3H mice (H-2(k)), and two (NP81, residues 81 to 95; and NP351, residues 351 to 365) in BALB/c mice (H-2(d)) have been identified. All of these peptides were able to stimulate the proliferation of NP-specific T-cell lines or freshly isolated lymph node cells from mice immunized with recombinant NP. Immunization of mice with synthetic peptides containing appropriate Th epitopes elicited strong cellular immunity in vivo, as evidenced by delayed-type hypersensitivity. Priming with the helper peptides (e.g., NP111 and NP351) significantly accelerated the immune response induced by recombinant NP, as determined by the production of NP-specific antibodies. When fused with a conserved neutralizing epitope (SP1143-1157) from the spike protein of SARS-CoV, NP111 and NP351 assisted in the production of high-titer neutralizing antibodies in vivo. These data provide useful insights regarding immunity against SARS-CoV and have the potential to help guide the design of peptide-based vaccines.

DOI: 10.1128/JVI.02568-06
PubMed: 17392374

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001E60
to stream PubMed, to step Curation: 001E60
to stream PubMed, to step Checkpoint: 001D88

Links to Exploration step

pubmed:17392374

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus.</title>
<author><name sortKey="Zhao, Jincun" sort="Zhao, Jincun" uniqKey="Zhao J" first="Jincun" last="Zhao">Jincun Zhao</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Immunology, Peking University Health Science Center, 38 Xueyuan Road, Beijing 100083, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Immunology, Peking University Health Science Center, 38 Xueyuan Road, Beijing 100083</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Huang, Qianrong" sort="Huang, Qianrong" uniqKey="Huang Q" first="Qianrong" last="Huang">Qianrong Huang</name>
</author>
<author><name sortKey="Wang, Wei" sort="Wang, Wei" uniqKey="Wang W" first="Wei" last="Wang">Wei Wang</name>
</author>
<author><name sortKey="Zhang, Yan" sort="Zhang, Yan" uniqKey="Zhang Y" first="Yan" last="Zhang">Yan Zhang</name>
</author>
<author><name sortKey="Lv, Ping" sort="Lv, Ping" uniqKey="Lv P" first="Ping" last="Lv">Ping Lv</name>
</author>
<author><name sortKey="Gao, Xiao Ming" sort="Gao, Xiao Ming" uniqKey="Gao X" first="Xiao-Ming" last="Gao">Xiao-Ming Gao</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17392374</idno>
<idno type="pmid">17392374</idno>
<idno type="doi">10.1128/JVI.02568-06</idno>
<idno type="wicri:Area/PubMed/Corpus">001E60</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001E60</idno>
<idno type="wicri:Area/PubMed/Curation">001E60</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001E60</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001D88</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001D88</idno>
<idno type="wicri:Area/Ncbi/Merge">001914</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus.</title>
<author><name sortKey="Zhao, Jincun" sort="Zhao, Jincun" uniqKey="Zhao J" first="Jincun" last="Zhao">Jincun Zhao</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Immunology, Peking University Health Science Center, 38 Xueyuan Road, Beijing 100083, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Immunology, Peking University Health Science Center, 38 Xueyuan Road, Beijing 100083</wicri:regionArea>
<placeName><settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Huang, Qianrong" sort="Huang, Qianrong" uniqKey="Huang Q" first="Qianrong" last="Huang">Qianrong Huang</name>
</author>
<author><name sortKey="Wang, Wei" sort="Wang, Wei" uniqKey="Wang W" first="Wei" last="Wang">Wei Wang</name>
</author>
<author><name sortKey="Zhang, Yan" sort="Zhang, Yan" uniqKey="Zhang Y" first="Yan" last="Zhang">Yan Zhang</name>
</author>
<author><name sortKey="Lv, Ping" sort="Lv, Ping" uniqKey="Lv P" first="Ping" last="Lv">Ping Lv</name>
</author>
<author><name sortKey="Gao, Xiao Ming" sort="Gao, Xiao Ming" uniqKey="Gao X" first="Xiao-Ming" last="Gao">Xiao-Ming Gao</name>
</author>
</analytic>
<series><title level="j">Journal of virology</title>
<idno type="ISSN">0022-538X</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Cell Line</term>
<term>Chlorocebus aethiops</term>
<term>Epitopes, T-Lymphocyte (administration & dosage)</term>
<term>Epitopes, T-Lymphocyte (chemistry)</term>
<term>Epitopes, T-Lymphocyte (isolation & purification)</term>
<term>Female</term>
<term>Humans</term>
<term>Immunodominant Epitopes (administration & dosage)</term>
<term>Immunodominant Epitopes (chemistry)</term>
<term>Immunodominant Epitopes (isolation & purification)</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Mice, Inbred C3H</term>
<term>Mice, Inbred C57BL</term>
<term>Molecular Sequence Data</term>
<term>Nucleocapsid Proteins (administration & dosage)</term>
<term>Nucleocapsid Proteins (chemistry)</term>
<term>Nucleocapsid Proteins (isolation & purification)</term>
<term>SARS Virus (chemistry)</term>
<term>SARS Virus (immunology)</term>
<term>T-Lymphocytes, Helper-Inducer (immunology)</term>
<term>T-Lymphocytes, Helper-Inducer (virology)</term>
<term>Vero Cells</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Cellules Vero</term>
<term>Données de séquences moléculaires</term>
<term>Déterminants antigéniques des lymphocytes T ()</term>
<term>Déterminants antigéniques des lymphocytes T (administration et posologie)</term>
<term>Déterminants antigéniques des lymphocytes T (isolement et purification)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Lymphocytes T auxiliaires (immunologie)</term>
<term>Lymphocytes T auxiliaires (virologie)</term>
<term>Mâle</term>
<term>Protéines nucléocapside ()</term>
<term>Protéines nucléocapside (administration et posologie)</term>
<term>Protéines nucléocapside (isolement et purification)</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Souris de lignée C3H</term>
<term>Souris de lignée C57BL</term>
<term>Séquence d'acides aminés</term>
<term>Virus du SRAS ()</term>
<term>Virus du SRAS (immunologie)</term>
<term>Épitopes immunodominants ()</term>
<term>Épitopes immunodominants (administration et posologie)</term>
<term>Épitopes immunodominants (isolement et purification)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Epitopes, T-Lymphocyte</term>
<term>Immunodominant Epitopes</term>
<term>Nucleocapsid Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Epitopes, T-Lymphocyte</term>
<term>Immunodominant Epitopes</term>
<term>Nucleocapsid Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>Epitopes, T-Lymphocyte</term>
<term>Immunodominant Epitopes</term>
<term>Nucleocapsid Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Déterminants antigéniques des lymphocytes T</term>
<term>Protéines nucléocapside</term>
<term>Épitopes immunodominants</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Lymphocytes T auxiliaires</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>SARS Virus</term>
<term>T-Lymphocytes, Helper-Inducer</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Déterminants antigéniques des lymphocytes T</term>
<term>Protéines nucléocapside</term>
<term>Épitopes immunodominants</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Lymphocytes T auxiliaires</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>T-Lymphocytes, Helper-Inducer</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Cell Line</term>
<term>Chlorocebus aethiops</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Mice, Inbred C3H</term>
<term>Mice, Inbred C57BL</term>
<term>Molecular Sequence Data</term>
<term>Vero Cells</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Cellules Vero</term>
<term>Données de séquences moléculaires</term>
<term>Déterminants antigéniques des lymphocytes T</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Mâle</term>
<term>Protéines nucléocapside</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Souris de lignée C3H</term>
<term>Souris de lignée C57BL</term>
<term>Séquence d'acides aminés</term>
<term>Virus du SRAS</term>
<term>Épitopes immunodominants</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">By using a series of overlapping synthetic peptides covering 98% of the amino acid sequence of the nucleocapsid protein (NP) of severe acute respiratory syndrome coronavirus (SARS-CoV), four helper T-cell (Th) epitopes (NP11, residues 11 to 25; NP51, residues 51 to 65; NP61, residues 61 to 75; and NP111, residues 111 to 125) in C57BL mice (H-2(b)), four (NP21, residues 21 to 35; NP91, residues 91 to 105; NP331, residues 331 to 345; and NP351, residues 351 to 365) in C3H mice (H-2(k)), and two (NP81, residues 81 to 95; and NP351, residues 351 to 365) in BALB/c mice (H-2(d)) have been identified. All of these peptides were able to stimulate the proliferation of NP-specific T-cell lines or freshly isolated lymph node cells from mice immunized with recombinant NP. Immunization of mice with synthetic peptides containing appropriate Th epitopes elicited strong cellular immunity in vivo, as evidenced by delayed-type hypersensitivity. Priming with the helper peptides (e.g., NP111 and NP351) significantly accelerated the immune response induced by recombinant NP, as determined by the production of NP-specific antibodies. When fused with a conserved neutralizing epitope (SP1143-1157) from the spike protein of SARS-CoV, NP111 and NP351 assisted in the production of high-titer neutralizing antibodies in vivo. These data provide useful insights regarding immunity against SARS-CoV and have the potential to help guide the design of peptide-based vaccines.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17392374</PMID>
<DateCompleted><Year>2007</Year>
<Month>07</Month>
<Day>12</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0022-538X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>81</Volume>
<Issue>11</Issue>
<PubDate><Year>2007</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus.</ArticleTitle>
<Pagination><MedlinePgn>6079-88</MedlinePgn>
</Pagination>
<Abstract><AbstractText>By using a series of overlapping synthetic peptides covering 98% of the amino acid sequence of the nucleocapsid protein (NP) of severe acute respiratory syndrome coronavirus (SARS-CoV), four helper T-cell (Th) epitopes (NP11, residues 11 to 25; NP51, residues 51 to 65; NP61, residues 61 to 75; and NP111, residues 111 to 125) in C57BL mice (H-2(b)), four (NP21, residues 21 to 35; NP91, residues 91 to 105; NP331, residues 331 to 345; and NP351, residues 351 to 365) in C3H mice (H-2(k)), and two (NP81, residues 81 to 95; and NP351, residues 351 to 365) in BALB/c mice (H-2(d)) have been identified. All of these peptides were able to stimulate the proliferation of NP-specific T-cell lines or freshly isolated lymph node cells from mice immunized with recombinant NP. Immunization of mice with synthetic peptides containing appropriate Th epitopes elicited strong cellular immunity in vivo, as evidenced by delayed-type hypersensitivity. Priming with the helper peptides (e.g., NP111 and NP351) significantly accelerated the immune response induced by recombinant NP, as determined by the production of NP-specific antibodies. When fused with a conserved neutralizing epitope (SP1143-1157) from the spike protein of SARS-CoV, NP111 and NP351 assisted in the production of high-titer neutralizing antibodies in vivo. These data provide useful insights regarding immunity against SARS-CoV and have the potential to help guide the design of peptide-based vaccines.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName>
<ForeName>Jincun</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Department of Immunology, Peking University Health Science Center, 38 Xueyuan Road, Beijing 100083, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Huang</LastName>
<ForeName>Qianrong</ForeName>
<Initials>Q</Initials>
</Author>
<Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Wei</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y"><LastName>Zhang</LastName>
<ForeName>Yan</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lv</LastName>
<ForeName>Ping</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gao</LastName>
<ForeName>Xiao-Ming</ForeName>
<Initials>XM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2007</Year>
<Month>03</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018984">Epitopes, T-Lymphocyte</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016056">Immunodominant Epitopes</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019590">Nucleocapsid Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C099602">nucleocapsid protein, Coronavirus</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018984" MajorTopicYN="N">Epitopes, T-Lymphocyte</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016056" MajorTopicYN="N">Immunodominant Epitopes</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008809" MajorTopicYN="N">Mice, Inbred C3H</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019590" MajorTopicYN="N">Nucleocapsid Proteins</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006377" MajorTopicYN="N">T-Lymphocytes, Helper-Inducer</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year>
<Month>3</Month>
<Day>30</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2007</Year>
<Month>7</Month>
<Day>13</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2007</Year>
<Month>3</Month>
<Day>30</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">17392374</ArticleId>
<ArticleId IdType="pii">JVI.02568-06</ArticleId>
<ArticleId IdType="doi">10.1128/JVI.02568-06</ArticleId>
<ArticleId IdType="pmc">PMC1900298</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Immunogenetics. 1999 Nov;50(3-4):213-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10602881</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2007 Mar 15;359(2):362-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17055551</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 May 30;300(5624):1399-404</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730501</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell Proteomics. 2003 May;2(5):346-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12775768</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2003 Dec 15;171(12):6339-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14662830</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Diagn Lab Immunol. 2004 Jan;11(1):227-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14715574</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Immunol Immunother. 2004 May;53(5):391-403</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14624313</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Lett. 2004 Apr 15;92(3):237-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15081618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 Jun 11;318(4):833-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15147946</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2004 Jul 15;190(2):379-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15216476</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9804-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15210961</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>DNA Cell Biol. 2004 Jun;23(6):391-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15231072</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Immunol. 2004 Sep;5(9):927-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15300249</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Res. 2004 Oct;105(2):121-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15351485</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunogenetics. 2004 Sep;56(6):405-19</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15349703</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1990 Apr 1;144(7):2730-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1690775</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1990 Jul 1;172(1):203-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1694217</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 1991 Jun;72 ( Pt 6):1293-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1710646</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Immunol. 1992 Oct;22(10):2675-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1382995</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Immunol. 1993 Mar;23(3):630-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7680611</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1995 Mar;69(3):1420-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7531779</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 1995 Oct 1;212(2):746-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7571447</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 1996 Aug;14(12):1143-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8911011</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2004 Nov;42(11):5309-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15528730</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 Dec 10;325(2):445-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15530413</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2004 Nov;10(11):1947-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15550204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2005 Jan 5;331(1):128-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15582659</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2005 May 2;23(24):3196-201</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15837220</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W180-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15980450</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biomed Sci. 2005 Oct;12(5):711-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16132115</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2006 Jan 30;24(5):652-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16214268</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2006 Mar 30;347(1):127-39</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16387339</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2006 Apr 12;24(16):3100-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16494977</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2006 May 26;344(1):63-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16630549</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Oral Microbiol Immunol. 2001 Feb;16(1):40-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11169138</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
<settlement><li>Pékin</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Gao, Xiao Ming" sort="Gao, Xiao Ming" uniqKey="Gao X" first="Xiao-Ming" last="Gao">Xiao-Ming Gao</name>
<name sortKey="Huang, Qianrong" sort="Huang, Qianrong" uniqKey="Huang Q" first="Qianrong" last="Huang">Qianrong Huang</name>
<name sortKey="Lv, Ping" sort="Lv, Ping" uniqKey="Lv P" first="Ping" last="Lv">Ping Lv</name>
<name sortKey="Wang, Wei" sort="Wang, Wei" uniqKey="Wang W" first="Wei" last="Wang">Wei Wang</name>
<name sortKey="Zhang, Yan" sort="Zhang, Yan" uniqKey="Zhang Y" first="Yan" last="Zhang">Yan Zhang</name>
</noCountry>
<country name="République populaire de Chine"><noRegion><name sortKey="Zhao, Jincun" sort="Zhao, Jincun" uniqKey="Zhao J" first="Jincun" last="Zhao">Jincun Zhao</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001914 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001914 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:17392374
   |texte=   Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:17392374" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus.

Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki